A detailed break-out of the company’s first quarter financial report shows its line of orthopedic products contributed approximately $39.6 million, indicating a 34 percent increase from the first quarter of last year. The increase stems from moderate orthopedic market growth, customer inventory builds and customer product launches.
Read the company news release about Greatbatch’s first quarter financial results.
Related Articles on Financial Results:
Biomet Announces 4Q FY 2010 Financial Results
NuVasive Reports 4Q Revenue of $129.3M, 20.9% Increase
Centinel Spine Reports 47% Increase in Q1 Sales
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
